An Exciting Strategic Collaboration between Dunad Therapeutics and Novartis to Develop Next-generation Oral Targeted Protein Degrader Therapies.
KEYWORDS: Dunad Therapeutics, a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies, announces that it has entered a strategic…